Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating expenses:
Research and development	$ 2,073,971	$ 3,033,539
General and administrative	1,917,030	333,529
Total operating expenses	3,991,001	3,367,068
Loss from operations	(3,991,001)	(3,367,068)
Other income (expense):
Interest income	30,690	0
Interest expense	0	(12,630)
Foreign currency transaction loss	(23,293)	0
Total other income (expense), net	7,397	(12,630)
Net loss	$ (3,983,604)	$ (3,379,698)
Net loss per share - basic and diluted	$ (0.53)	$ (1.38)
Weighted average common shares outstanding - basic and diluted	7,497,433	2,450,000